KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Idexx Laboratories (IDXX) EPS (Basic) (2016 - 2025)

Idexx Laboratories has reported EPS (Basic) over the past 17 years, most recently at $3.11 for Q4 2025.

  • Quarterly results put EPS (Basic) at $3.11 for Q4 2025, up 17.36% from a year ago — trailing twelve months through Dec 2025 was $13.18 (up 22.26% YoY), and the annual figure for FY2025 was $13.17, up 22.28%.
  • EPS (Basic) for Q4 2025 was $3.11 at Idexx Laboratories, down from $3.43 in the prior quarter.
  • Over the last five years, EPS (Basic) for IDXX hit a ceiling of $3.66 in Q2 2025 and a floor of $1.57 in Q2 2022.
  • Median EPS (Basic) over the past 5 years was $2.5 (2023), compared with a mean of $2.55.
  • Biggest five-year swings in EPS (Basic): surged 82.44% in 2021 and later tumbled 33.76% in 2022.
  • Idexx Laboratories' EPS (Basic) stood at $1.92 in 2021, then increased by 8.33% to $2.08 in 2022, then grew by 12.5% to $2.34 in 2023, then increased by 13.25% to $2.65 in 2024, then grew by 17.36% to $3.11 in 2025.
  • The last three reported values for EPS (Basic) were $3.11 (Q4 2025), $3.43 (Q3 2025), and $3.66 (Q2 2025) per Business Quant data.